RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Cardiac Surgery
Interventions
DEVICE

IMPELLA LP/LD 5.0

IMPELLA LP/LD 5.0 Support System is intended to be used for up to seven (7) days as a left ventricular cardiac assist device for postcardiotomy patients who, despite having been weaned from cardiopulmonary bypass (CPB), require hemodynamic support

Trial Locations (7)

10032

Columbia Presbyterian Hospital, New York

17033

Hershey Medical Center, Hershey

21201

University of Maryland, Baltimore

777030

Texas Heart, Houston

02114

Massach General Hospital, Boston

02115

Brigham & Womens, Boston

08903

Robert Wood Johnson, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abiomed Inc.

INDUSTRY

NCT00596726 - RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility Study | Biotech Hunter | Biotech Hunter